The effects of maternal thyroid hormone function on early pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 25, Issue 4, 2013, Pages 267-273

  Bernardi, Lia A ^a   Scoccia, Bert ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

infertility; pregnancy; screening; subclinical hypothyroidism; thyroid

Indexed keywords

THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

AUTOIMMUNITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHYROIDISM; OVARY HYPERSTIMULATION; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SCREENING; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION;

CLINICAL TRIALS AS TOPIC; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYPOTHYROIDISM; INFERTILITY; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THYROID DISEASES; THYROID GLAND; THYROID HORMONES;

EID: 84880780469     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283630d80     Document Type: Review

References (35)

1. Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol 2012; 8:650-658.
2. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31:702-755.
3. Casey BM, Leveno KJ. Thyroid disease in pregnancy. Obstet Gynecol 2006; 108:1283-1292.
4. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18:404-433.
5. ACOG Committee Opinion No. 381. Subclinical hypothyroidism in pregnancy. Obstet Gynecol 2007; 110:959-960.
6. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21:1081-1125.
7. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97:2543-2565.
8. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22:1200-1235.
9. Gharib H, Tuttle RM, Baskin HJ, et al. Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid 2005; 15:24-28.
10. Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009; 200:267e1-267e7.
11. Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 2008; 158:841-851.
12. Dosiou C, Barnes J, Schwartz A, et al. Cost-effectiveness of universal and riskbased screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 2012; 97:1536-1546.
13. Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007; 92:203-207.
14. Goel P, Kaur J, Saha PK, et al. Prevalence, associated risk factors and effects of hypothyroidism in pregnancy: a study from north India. Gynecol Obstet Invest 2012; 74:89-94.
15. Potlukova E, Potluka O, Jiskra J, et al. Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women. J Clin Endocrinol Metab 2012; 97:1945-1952.
16. Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 2012; 97:777-784.
17. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91:2587-2591.
18. Negro R, Schwartz A, Gismondi R, et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95:1699-1707.
19. Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95:E44-E48.
20. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12:63-68.
21. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 105:239-245.
22. Casey BM, Dashe JS, Spong CY, et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007; 109:1129-1135.
23. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112:85-92.
24. Lepoutre T, Debieve F, Gruson D, Daumerie C. Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Invest 2012; 74:265-273.
25. Yan J, Sripada S, Saravelos SH, et al. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril 2012; 98:378-382.
26. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:549-555.
27. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366:493-501.
28. Julvez J, Alvarez-Pedrerol M, Rebagliato M, et al. Thyroxine levels during pregnancy in healthy women and early child neurodevelopment. Epidemiology 2013; 24:150-157.
29. Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012; 97:2396-2403.
30. Vissenberg R, van den Boogaard E, van Wely M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update 2012; 18:360-373.
31. Gracia CR, Morse CB, Chan G, et al. Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertil Steril 2012; 97:585-591.
32. Kim CH, Ahn JW, Kang SP, et al. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2011; 95:1650-1654.
33. Scoccia B, Demir H, Kang Y, et al. In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders. Thyroid 2012; 22:631-636.
34. Zhong YP, Ying Y, Wu HT, et al. Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci 2012; 9:121-125.
35. Velkeniers B, Van Meerhaeghe A, Poppe K, et al. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update 2013; 19:251-258; doi: 10. 093/humupd/ dms052.